ARDS
Aridis Pharmaceuticals Inc
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
aridis is a privately held infectious diseases focused company in san jose, ca, usa. aridis’ advanced formulation and delivery technologies are combined with proprietary products portfolio to create potent drug candidates that are packaged into convenient to administer, "ready-to-use" formats.
Market Cap: 9.53 Million
Primary Exchange: NASDAQ
Website: aridispharma.com
Shares Outstanding: 36.2 Million
Float: 0
Dividend: 0.0 (0.0%)
Beta: 0.0
Sector: Professional, Scientific, and Technical Services
Industry: Research and Development in Biotechnology
Ethical Flags
Longest drawdown: 1548 trading days
From: 2018-09-04 To: 2023-07-18
Lowest Point:
Aridis Pharmaceuticals Appoints Dr. Susan Windham-Bannister to Board of Directors
via: PR Newswire at 2019-06-10 01:30:00:000
SAN JOSE, Calif. , June 10, 2019 /PRNewswire/ -- Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of targeted immunotherapies using fully human monoclonal antibodies (mAbs) to treat life-threatening bacterial infectio… read more...
Aridis Pharmaceuticals Appoints Dr. Susan Windham-Bannister to Board of Directors
via: PR Newswire at 2019-06-10 01:30:00:000
SAN JOSE, Calif. , June 10, 2019 /PRNewswire/ -- Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of targeted immunotherapies using fully human monoclonal antibodies (mAbs) to treat life-threatening bacterial infectio… read more...
Aridis Pharmaceuticals Appoints Dr. Susan Windham-Bannister to Board of Directors
via: PR Newswire at 2019-06-10 01:30:00:000
SAN JOSE, Calif. , June 10, 2019 /PRNewswire/ -- Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of targeted immunotherapies using fully human monoclonal antibodies (mAbs) to treat life-threatening bacterial infectio… read more...
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|